Back
to sessions
Sep 29
Quick Pitch
QP 29 - Response Assessment and Risk Stratification in Gynecologic Cancers: Biomarkers, Imaging, and Outcomes
MODERATOR(S)
Stephanie Markovina, MD, PhD - Washington University
Christopher Weil, MD, MS - MD Anderson Cancer Center
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
05:15pm - 05:20pm ETSpeaker: Stephanie Markovina, MD, PhD - Washington University, St. Louis
-
05:20pm - 05:25pm ET
Post-Treatment SCC-Ag vs. FDG-PET/CT Metabolic Response in Prognostic Stratification of Patients with Locally Advanced Cervical Cancer Treated with Concurrent Chemoradiotherapy
Speaker: Qian Zhu, MD, PhD - Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai -
05:25pm - 05:30pm ET
RSI-Based Radiogenomic Characterization of Cervical Cancer Reveals Intrinsic Radiosensitivity Heterogeneity and Translational Concordance
Speaker: Anuoluwapo Ajao, BS - Case Western Reserve School of Medicine, Cleveland -
05:30pm - 05:35pm ET
Association Between Plasma and Urine HPV Circulating Tumor DNA and Early Treatment Response in Locally Advanced Cervical Cancer Treated with Concurrent Chemoradiation
Speaker: Chinnavuth Vatanashevanopakorn, MD, PhD - Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkoknoi -
05:35pm - 05:40pm ETSpeaker: Nilanjana Dahiya, MD - Kidwai Memorial Institute of Oncology, Bangalore
-
05:40pm - 05:45pm ETSpeaker: Mary-Kate Lawlor, MD - Yale New Haven Health, New Haven
-
05:45pm - 05:50pm ET
Five-Year Longitudinal Study of Quality of Life after Chemoradiotherapy Treatment of Cervical Cancer in Botswana
Speaker: Mae Ross Brockman, None - University of North Carolina at Chapel Hill, Chapel Hill -
05:50pm - 06:10pm ETSpeaker: Christopher Weil, MD, MS - MD Anderson Cancer Center, Houston
-
06:10pm - 06:15pm ETSpeaker: Stephanie Markovina, MD, PhD - Washington University, St. Louis